S. Vincent Rajkumar, a professor of Medicine at the Mayo Clinic, Rochester, Minnesota, discusses the prevalence of quadruplet regimens in treating patients with multiple myeloma. Choices for patients who have experiences ≥2 relapses are complicated and quadruplet regimens are stepping in as a viable option for clinicians, says Rajkumar. However, there are considerations to take into account including access to drugs and cost of the therapy.
